Genentech recently published a groundbreaking visual explanation focusing on recent medical breakthroughs in the fight to end cancer. Highlighted in this rich history is Friends of Cancer Research (Friends) chairperson and founder, Ellen Sigal, for her contribution as a patient advocate and her work at Friends. Friends was pivotal in creating the breakthrough therapy designation, moving it from an idea to reality in just 13 months.

Access the full story here and read more below about how Friends powers advances in science, policy, and regulation that speed life-saving treatments to patients.